Acarix AB (publ) (ACARIX.ST)
SEK 0.22
(4.18%)
SEK 0.22
(4.18%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 6.83 Million SEK | 30.32% |
| 2022 | 5.24 Million SEK | 45.74% |
| 2021 | 3.6 Million SEK | 4.77% |
| 2020 | 3.43 Million SEK | 12.61% |
| 2019 | 3.05 Million SEK | 16.27% |
| 2018 | 2.62 Million SEK | 34.96% |
| 2017 | 1.94 Million SEK | 148.2% |
| 2016 | -4.03 Million SEK | 10.89% |
| 2015 | -4.52 Million SEK | 0.0% |
| 2014 | - SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 5.98 Million SEK | -14.44% |
| 2024 Q1 | 6.98 Million SEK | 2.19% |
| 2023 Q1 | 5.98 Million SEK | 14.01% |
| 2023 Q3 | 7.33 Million SEK | 12.0% |
| 2023 Q2 | 6.55 Million SEK | 9.48% |
| 2023 Q4 | 6.83 Million SEK | -6.77% |
| 2023 FY | 6.83 Million SEK | 30.32% |
| 2022 Q4 | 5.24 Million SEK | 1.14% |
| 2022 Q2 | 4.57 Million SEK | 32.43% |
| 2022 Q1 | 3.45 Million SEK | -4.17% |
| 2022 FY | 5.24 Million SEK | 45.74% |
| 2022 Q3 | 5.18 Million SEK | 13.54% |
| 2021 Q1 | 3.55 Million SEK | 3.35% |
| 2021 FY | 3.6 Million SEK | 4.77% |
| 2021 Q2 | 3.78 Million SEK | 6.56% |
| 2021 Q3 | 3.71 Million SEK | -1.77% |
| 2021 Q4 | 3.6 Million SEK | -3.15% |
| 2020 Q1 | 3.99 Million SEK | 30.93% |
| 2020 FY | 3.43 Million SEK | 12.61% |
| 2020 Q2 | 3.1 Million SEK | -22.22% |
| 2020 Q3 | 3.15 Million SEK | 1.61% |
| 2020 Q4 | 3.43 Million SEK | 8.83% |
| 2019 Q4 | 3.05 Million SEK | -9.49% |
| 2019 FY | 3.05 Million SEK | 16.27% |
| 2019 Q3 | 3.37 Million SEK | -1.6% |
| 2019 Q2 | 3.42 Million SEK | 3.01% |
| 2019 Q1 | 3.32 Million SEK | 26.74% |
| 2018 FY | 2.62 Million SEK | 34.96% |
| 2018 Q4 | 2.62 Million SEK | 3.39% |
| 2018 Q1 | 3.06 Million SEK | 57.53% |
| 2018 Q3 | 2.53 Million SEK | -13.9% |
| 2018 Q2 | 2.94 Million SEK | -3.75% |
| 2017 Q2 | 1.59 Million SEK | 205.77% |
| 2017 Q4 | 1.94 Million SEK | 19.11% |
| 2017 FY | 1.94 Million SEK | 148.2% |
| 2017 Q1 | 520 Thousand SEK | 0.0% |
| 2017 Q3 | 1.63 Million SEK | 2.7% |
| 2016 Q1 | - SEK | 0.0% |
| 2016 Q4 | - SEK | 0.0% |
| 2016 Q3 | - SEK | 0.0% |
| 2016 FY | -4.03 Million SEK | 10.89% |
| 2015 Q4 | - SEK | 0.0% |
| 2015 FY | -4.52 Million SEK | 0.0% |
| 2014 FY | - SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| ADDvise Group AB (publ) | 121.2 Million SEK | 94.357% |
| ADDvise Group AB (publ) | 121.2 Million SEK | 94.357% |
| Arcoma AB | 28.02 Million SEK | 75.599% |
| Bactiguard Holding AB (publ) | 29.64 Million SEK | 76.931% |
| BICO Group AB (publ) | 493.1 Million SEK | 98.613% |
| Boule Diagnostics AB (publ) | 62.4 Million SEK | 89.04% |
| CellaVision AB (publ) | 126.03 Million SEK | 94.574% |
| Clinical Laserthermia Systems AB (publ) | 6.11 Million SEK | -11.84% |
| Chordate Medical Holding AB (publ) | 1.77 Million SEK | -286.183% |
| C-Rad AB (publ) | 64.09 Million SEK | 89.331% |
| Duearity AB (publ) | 4.15 Million SEK | -64.439% |
| Dignitana AB (publ) | 7.41 Million SEK | 7.743% |
| Episurf Medical AB (publ) | 3.7 Million SEK | -84.838% |
| Getinge AB (publ) | 6.41 Billion SEK | 99.893% |
| Scandinavian Real Heart AB (Publ) | -1.68 Million SEK | 506.268% |
| Iconovo AB (publ) | -4.86 Million SEK | 240.662% |
| Integrum AB (publ) | 22.36 Million SEK | 69.417% |
| Luxbright AB (publ) | 8000.00 SEK | -85387.5% |
| Mentice AB (publ) | 14.1 Million SEK | 51.51% |
| OssDsign AB (publ) | 4.3 Million SEK | -58.899% |
| Paxman AB (publ) | 19.99 Million SEK | 65.803% |
| Promimic AB (publ) | 330 Thousand SEK | -1972.424% |
| Qlife Holding AB (publ) | 7.29 Million SEK | 6.212% |
| SciBase Holding AB (publ) | 11.91 Million SEK | 42.621% |
| ScandiDos AB (publ) | 22.69 Million SEK | 69.859% |
| Sectra AB (publ) | 36.59 Million SEK | 81.309% |
| Sedana Medical AB (publ) | 42.97 Million SEK | 84.086% |
| Senzime AB (publ) | 20.34 Million SEK | 66.377% |
| SpectraCure AB (publ) | 1.00 SEK | -683899900.0% |
| Stille AB | 66.55 Million SEK | 89.724% |
| Vitrolife AB (publ) | 413 Million SEK | 98.344% |
| Xvivo Perfusion AB (publ) | 141.6 Million SEK | 95.17% |